Literature DB >> 10212311

Catecholamine synthesis is mediated by tyrosinase in the absence of tyrosine hydroxylase.

M Rios1, B Habecker, T Sasaoka, G Eisenhofer, H Tian, S Landis, D Chikaraishi, S Roffler-Tarlov.   

Abstract

Catecholamine neurotransmitters are synthesized by hydroxylation of tyrosine to L-dihydroxyphenylalanine (L-Dopa) by tyrosine hydroxylase (TH). The elimination of TH in both pigmented and albino mice described here, like pigmented TH-null mice reported previously (Kobayashi et al., 1995; Zhou et al., 1995), demonstrates the unequivocal requirement for catecholamines during embryonic development. Although the lack of TH is fatal, TH-null embryos can be rescued by administration of catecholamine precursors to pregnant dams. Once born, TH-null pups can survive without further treatment until weaning. Given the relatively rapid half-life of catecholamines, we expected to find none in postnatal TH-null pups. Despite the fact that the TH-null pups lack TH and have not been supplemented with catecholamine precursers, catecholamines are readily detected in our pigmented line of TH-null mice by glyoxylic acid-induced histofluorescence at postnatal day 7 (P7) and P15 and quantitatively at P15 in sympathetically innervated peripheral organs, in sympathetic ganglia, in adrenal glands, and in brains. Between 2 and 22% of wild-type catecholamine concentrations are found in these tissues in mutant pigmented mice. To ascertain the source of the catecholamine, we examined postnatal TH-null albino mice that lack tyrosinase, another enzyme that converts tyrosine to L-Dopa but does so during melanin synthesis. In contrast to the pigmented TH-null mice, catecholamine histofluorescence is undetectable in postnatal albino mutants, and the catecholamine content of TH-null pups lacking tyrosinase is 18% or less than that of TH-null mice with tyrosinase. Thus, these extraordinary circumstances reveal that tyrosinase serves as an alternative pathway to supply catecholamines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10212311      PMCID: PMC6782225     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  19 in total

1.  TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS.

Authors:  T NAGATSU; M LEVITT; S UDENFRIEND
Journal:  J Biol Chem       Date:  1964-09       Impact factor: 5.157

2.  Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.

Authors:  G Eisenhofer; D S Goldstein; R Stull; H R Keiser; T Sunderland; D L Murphy; I J Kopin
Journal:  Clin Chem       Date:  1986-11       Impact factor: 8.327

3.  Tyrosinase is a new marker for cell populations in the mouse neural tube.

Authors:  K Tief; A Schmidt; A Aguzzi; F Beermann
Journal:  Dev Dyn       Date:  1996-04       Impact factor: 3.780

4.  Tyrosinase mRNA is expressed in human substantia nigra.

Authors:  Y Xu; A H Stokes; W M Freeman; S C Kumer; B A Vogt; K E Vrana
Journal:  Brain Res Mol Brain Res       Date:  1997-04

Review 5.  Tyrosinase: a comprehensive review of its mechanism.

Authors:  A Sánchez-Ferrer; J N Rodríguez-López; F García-Cánovas; F García-Carmona
Journal:  Biochim Biophys Acta       Date:  1995-02-22

6.  Regional studies of catecholamines in the rat brain. II. Rate of turnover of catecholamines in various brain regions.

Authors:  L L Iversen; J Glowinski
Journal:  J Neurochem       Date:  1966-08       Impact factor: 5.372

7.  Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development.

Authors:  Q Y Zhou; C J Quaife; R D Palmiter
Journal:  Nature       Date:  1995-04-13       Impact factor: 49.962

8.  Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic.

Authors:  Q Y Zhou; R D Palmiter
Journal:  Cell       Date:  1995-12-29       Impact factor: 41.582

9.  Tyrosinase-like activity in normal human substantia nigra.

Authors:  M Miranda; D Botti; A Bonfigli; T Ventura; A Arcadi
Journal:  Gen Pharmacol       Date:  1984

10.  Molecular characterization of the mouse tyrosinase gene: pigment cell-specific expression in transgenic mice.

Authors:  F Beermann; E Schmid; R Ganss; G Schütz; S Ruppert
Journal:  Pigment Cell Res       Date:  1992-11
View more
  37 in total

1.  Modest neuropsychological deficits caused by reduced noradrenaline metabolism in mice heterozygous for a mutated tyrosine hydroxylase gene.

Authors:  K Kobayashi; Y Noda; N Matsushita; K Nishii; H Sawada; T Nagatsu; D Nakahara; R Fukabori; Y Yasoshima; T Yamamoto; M Miura; M Kano; T Mamiya; Y Miyamoto; T Nabeshima
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

Review 2.  Lessons learned from gene targeting and transgenesis for adrenal physiology and disease.

Authors:  A Böttner; S R Bornstein
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

Review 3.  Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma.

Authors:  Thamara E Osinga; Thera P Links; Robin P F Dullaart; Karel Pacak; Anouk N A van der Horst-Schrivers; Michiel N Kerstens; Ido P Kema
Journal:  FASEB J       Date:  2017-03-06       Impact factor: 5.191

4.  A tyrosine hydroxylase-yellow fluorescent protein knock-in reporter system labeling dopaminergic neurons reveals potential regulatory role for the first intron of the rodent tyrosine hydroxylase gene.

Authors:  B B Kelly; E Hedlund; C Kim; H Ishiguro; O Isacson; D M Chikaraishi; K-S Kim; G Feng
Journal:  Neuroscience       Date:  2006-07-31       Impact factor: 3.590

5.  Strengths and limitations of morphological and behavioral analyses in detecting dopaminergic deficiency in Caenorhabditis elegans.

Authors:  Latasha L Smith; Ian T Ryde; Jessica H Hartman; Riccardo F Romersi; Zachary Markovich; Joel N Meyer
Journal:  Neurotoxicology       Date:  2019-07-16       Impact factor: 4.294

6.  A transgenic mouse model of neuroepithelial cell specific inducible overexpression of dopamine D1-receptor.

Authors:  K Fujimoto; K Araki; D M McCarthy; J R Sims; J Q Ren; X Zhang; P G Bhide
Journal:  Neuroscience       Date:  2010-07-29       Impact factor: 3.590

Review 7.  Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease.

Authors:  Masato Asanuma; Ikuko Miyazaki; Norio Ogawa
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

8.  Increased FGF21 in brown adipose tissue of tyrosine hydroxylase heterozygous mice: implications for cold adaptation.

Authors:  Patricia Vázquez; Catalina Hernández-Sánchez; Carmen Escalona-Garrido; Laura Pereira; Cristina Contreras; Miguel López; Jesús Balsinde; Flora de Pablo; Ángela M Valverde
Journal:  J Lipid Res       Date:  2018-10-23       Impact factor: 5.922

9.  Elevated dopamine levels during gestation produce region-specific decreases in neurogenesis and subtle deficits in neuronal numbers.

Authors:  Deirdre McCarthy; Paula Lueras; Pradeep G Bhide
Journal:  Brain Res       Date:  2007-09-21       Impact factor: 3.252

10.  The C. elegans D2-like dopamine receptor DOP-3 decreases behavioral sensitivity to the olfactory stimulus 1-octanol.

Authors:  Meredith J Ezak; Denise M Ferkey
Journal:  PLoS One       Date:  2010-03-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.